<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-ZWE-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Zimbabwe (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Zimbabwe: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org ref="GB-COH-03259922" role="4" type="70">
   <narrative xml:lang="EN">Crown Agents Limited</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Zimbabwe</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ZW" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="ZW" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Harare</narrative>
   </name>
   <administrative code="ZW" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-17.82935 31.05389</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1479570</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2643332</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1838495</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">62934</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="ZWEPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">56000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">522823</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">122614</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">275832</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">494460</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">546222</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">122720</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">487610</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">12733</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">665334</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">808713</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">202617</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-CROWN AGENTS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">194100</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CROWN AGENTS (Crown Agents Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Crown Agents Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">409236</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">510188</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">32126</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">260760</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">229469</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">29181</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-CROWN AGENTS2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">33753</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CROWN AGENTS (Crown Agents Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Crown Agents Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZWEPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000929">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">56000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003436">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">41226</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">43778</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001233">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">88432</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700002694">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-01"></transaction-date>
   <value currency="USD" value-date="2021-05-01">-66175</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700002694">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-01"></transaction-date>
   <value currency="USD" value-date="2021-05-01">66175</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">76070</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CROWN AGENTS (Crown Agents Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="GB-COH-03259922" type="70">
    <narrative xml:lang="EN">Crown Agents Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-22"></transaction-date>
   <value currency="USD" value-date="2021-11-22">84277</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CROWN AGENTS (Crown Agents Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="GB-COH-03259922" type="70">
    <narrative xml:lang="EN">Crown Agents Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001036">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">51898</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001202">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">37689</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001332">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-89588</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003843">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">114231</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">184649</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001273">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-15950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-91073</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">121382</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001311">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">27438</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001258">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">91073</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">91073</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-121382</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000517">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-25"></transaction-date>
   <value currency="USD" value-date="2020-02-25">92579</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001403">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">28803</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001498">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">65086</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005461">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="USD" value-date="2020-12-15">17634</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002310">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">54889</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">109661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006733">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">201259</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007330">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">21836</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">14828</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">122614</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">100000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">20999</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001267">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">187750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">229106</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006424">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">86242</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">733</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-8126</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">8126</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">1500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">6000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">2400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000930">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">275832</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">247104</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">418230</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">260760</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000931">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">494460</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">463510</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">345203</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">229469</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-zimbabwe-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zimbabwe 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zimbabwe-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zimbabwe 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-zimbabwe-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zimbabwe 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zimbabwe-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zimbabwe 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-zimbabwe-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zimbabwe 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zimbabwe-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zimbabwe 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zimbabwe-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zimbabwe 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zimbabwe-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zimbabwe 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-ZWE" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CCEOP plan is at 100% of implementation countrywide by Q2 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA for immunisation Supply Chain Management (iSCM)">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">86% of the CCE installed as on 04 June 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA for immunisation Supply Chain Management (iSCM)">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">86% of the CCE installed as on 04 June 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 60% of activities in the Demand Promotion Strategy and CEA recomendations implemented in all provinces by Q2 2021.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="C4D/SBCC Technical assistance- Health Promotion Officer to be based at the MoHCC central level">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">100% of SBCC demand package is now integrated within the RMNCH &amp; N interventions targeted across 63 districts to increase awareness, acceptability and uptake of immunisation services; using the socio-ecological model targeting individual, community and organisational structures through interpersonal communication strategies implemented by a network of more than 16,000 Village Health Workers, health promotion activities at service points, media engagements, mass media campaign to promote vaccination as a prevention strategy and capacity building and orientation of community influencers on benefits of immunisation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="C4D/SBCC Technical assistance- Health Promotion Officer to be based at the MoHCC central level">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">100% of SBCC demand package is now integrated within the RMNCH &amp; N interventions targeted across 63 districts to increase awareness, acceptability and uptake of immunisation services; using the socio-ecological model targeting individual, community and organisational structures through interpersonal communication strategies implemented by a network of more than 16,000 Village Health Workers, health promotion activities at service points, media engagements, mass media campaign to promote vaccination as a prevention strategy and capacity building and orientation of community influencers on benefits of immunisation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report documenting the process and lessons learned from the TCV and IPV catch up campaign is produced and shared to relevant stakeholdersby Q3 2020.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Documentation of human interest stories in EPI and best practices for RI, new vaccine introduction and community dialogues">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Campaign was delayed and was only implemented 24 May-04 June 2021. However, the campaign failed to reach the 90% target coverage within this period hence mop up activities are ongoing upto the first week of July 2021. Therefore, a report will be available Q3 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 30% of activities in the Demand Promotion Strategy and CEA recomendations implemented in all provinces by Q4 2020.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="C4D/SBCC Technical assistance- Health Promotion Officer to be based at the MoHCC central level">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Hundred percent coverage and ongoing activities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Multi-media campaign on 63 districts implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Integrated Vaccine for Prevention campaign implemented in 63 districts through multi-media channels 

Collect caregiver feedback on immunisation services including COVID-19">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of caregivers who report that they know where to access immunisation information and services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Integrated Vaccine for Prevention campaign implemented in 63 districts through multi-media channels 

Collect caregiver feedback on immunisation services including COVID-19">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of provinces have updated CCE management documents like CCE inventory, Operational Deployment Plan (ODP) or Cold Chain Expansion and Rehabilitation Plan, CCE maintenance strategy etc.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="- Initiate procurement, support distribution and installation of CCE procured under Gavi CCEOP including Covid-19 CCE
- Support vaccine and supplies forecasting, procurement, receipt and distribution including tracking shipments and payments including Covid-19 vaccine.
- Ensure timely availability of vaccines and supplies from suppliers
- Ensure all Gavi HSS Procurements are initiated and completed in time
- Supporting procurement of LP gas and other EPI equipment as well as monitoring distribution and usage the materials
- Ensure equitable distribution of vaccines and other EPI supplies for routine and campaign activities

- Periodic reporting of vaccine and supplies status including Covid-19 vaccine and accessories
- Reporting on Vaccine &amp; Product arrivals to Supply Division thus ensuring that feedback is used to inform the supply chain

- Assisting in planning for preventive maintenance, trouble shooting where necessary and follow up technical support in a timely manner for major repairs and replacement of parts.
- Support and build the capacity of the EPI team and others partners for undertaking regular and quality monitoring of progress as per the monitoring framework of the EPI 

- Timely construction of Dry Store facilities and 4 health posts to ensure proper storage and access 

- Support development of iSCM components of key EPI documents -cMYP, GAVI proposals and other documents
- TA for implementation of EVM IP, cold chain/ vaccine management, Cold Chain Assessment and other EPI trainings">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">1,051 Solar Direct Drive refrigerators procured and installed at service delivery points in all districts country wide. The equipment was procured under funding from the CCEOP (968 pieces) and Performance Bonus awarded to the country (83 pieces). Additional CCE mobilised as response to capacity requirements for COVID-19 vaccines coming through Japanese grant and COVAX Support is expected in country beginning Q4 2021.
LP Gas procurement and distribution was conducted upto Q2 2021, and indications are that the immunisation program may no longer need gas for cold chain in future because all health centres will be using solar power.
Vaccines and supplies, including COVID-19 received timely and distribution to lower levels has been conducted. 
Construction of the Dry Stores and four health posts commenced October 2021 and is expected to be completed Q1 2022.
The National Immunisation Strategy (cMYP) has been initiated and is expected to be finalised by end of November 2021. The draft document is attached.
EVM Review conducted for all districts; activity was done in two clusters with participants drawn from Provincial and District Focal persons. There has been improvement in reporting and vaccine management.
The EVM IP has been finalised and activities have been incorporated into future plans. The Cold Chain Assessment is now planned for 2022.
Weekly Vaccine Sitrep has been shared periodically and this has helped in tracking vaccine availability at subnational level.
Immunisation Forecast for 2022 supplies has been conducted and the first consignments are anticipated Q4 2021.
Preventive maintenance of CCE has been conducted and equipment is functioning properly at all levels.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">[Y/N] Evaluation (e.g. EVMA, CCI, system redesign) completed and submitted to MoH, including supporting analysis of VfM and zero-dose considerations (as applicable)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="- Initiate procurement, support distribution and installation of CCE procured under Gavi CCEOP including Covid-19 CCE
- Support vaccine and supplies forecasting, procurement, receipt and distribution including tracking shipments and payments including Covid-19 vaccine.
- Ensure timely availability of vaccines and supplies from suppliers
- Ensure all Gavi HSS Procurements are initiated and completed in time
- Supporting procurement of LP gas and other EPI equipment as well as monitoring distribution and usage the materials
- Ensure equitable distribution of vaccines and other EPI supplies for routine and campaign activities

- Periodic reporting of vaccine and supplies status including Covid-19 vaccine and accessories
- Reporting on Vaccine &amp; Product arrivals to Supply Division thus ensuring that feedback is used to inform the supply chain

- Assisting in planning for preventive maintenance, trouble shooting where necessary and follow up technical support in a timely manner for major repairs and replacement of parts.
- Support and build the capacity of the EPI team and others partners for undertaking regular and quality monitoring of progress as per the monitoring framework of the EPI 

- Timely construction of Dry Store facilities and 4 health posts to ensure proper storage and access 

- Support development of iSCM components of key EPI documents -cMYP, GAVI proposals and other documents
- TA for implementation of EVM IP, cold chain/ vaccine management, Cold Chain Assessment and other EPI trainings">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">EVMA was conducted Q1 2020 but implementation of recommendations was delayed due to the COVID-19 pandemic. The National Immunisation Strategy which is being developed will address critical EVM issues which require attention.
The national Cold Chain Assessment will be conducted in 2022. 
Cold Chain Inventory has been conducted to identify gaps for support as part of the fight against COVID-19 pandemic. Findings have informed the need for additional CCE at provincial and district levels; procurement has been initiated with funding from Japan and the COVAX Facility, delivery is now expected beginning Q4 as mentioned earlier.
All other EVM activities have been implemented as mentioned above.
The MoHCC has proposed the need for procurement of refrigerated trucks for vaccine distribution and this is still being discussed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">75% CCEOP Deployment Plan Implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Minitoring installation and commissioning of CCE procured under Gavi CCEOP">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Installation of CCE is almost complete 913 of the first lot of 968 SSD refrigerators having been installed by end of May 2021. The company doing the installation is in the process of installing the second lot of 83 refrigerators and the balance of the first lot. Our expectation is for them to have completed the installation by end June 2021. This will immediately be followed by commissioning the refrigrators.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Minitoring installation and commissioning of CCE procured under Gavi CCEOP">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Installation of CCE is almost complete 913 of the first lot of 968 SSD refrigerators having been installed by end of May 2021. The company doing the installation is in the process of installing the second lot of 83 refrigerators and the balance of the first lot. Our expectation is for them to have completed the installation by end June 2021. This will immediately be followed by commissioning the refrigrators.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5 national and 55 provincial 2020 quarters 1, 2, 3 and 4 for 2020 and quarter 1 of 2021 SMTs analysed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Roll out of the New WHO Stock Management Tool
Offer technical support in identifying and trial running of real time LMIS 
Visit 6 provinces and 16 districts to support them on supplies management 
Support MOHCC in TCV vaccine introduction
 Provide technical support in smooth operationalisation and analysis of SMT 
 Offer technical support in deployment of CCE procured under Gavi CCEOP">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The 2021 version of the SMT was successfully rolled out to all provinces and districts in the country. Due to Covid-19 pandemic, technical support was remotely provided to all provinces and districts that required the support. The country managed to carry out two rounds of integrated supportive visits to all provinces and at least four districts in each province when Covid-19 restrictions were relaxed.
What the country failed to do because of Covid-19 pandemic was the trial of the planned introduction of a real time LMIS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Roll out of the New WHO Stock Management Tool
Offer technical support in identifying and trial running of real time LMIS 
Visit 6 provinces and 16 districts to support them on supplies management 
Support MOHCC in TCV vaccine introduction
 Provide technical support in smooth operationalisation and analysis of SMT 
 Offer technical support in deployment of CCE procured under Gavi CCEOP">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The 2021 version of the SMT was successfully rolled out to all provinces and districts in the country. Due to Covid-19 pandemic, technical support was remotely provided to all provinces and districts that required the support. The country managed to carry out two rounds of integrated supportive visits to all provinces and at least four districts in each province when Covid-19 restrictions were relaxed.
What the country failed to do because of Covid-19 pandemic was the trial of the planned introduction of a real time LMIS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Best practices and lessons learned from situational analyses implementation, microplanning, and action plan development documented and shared with the ICC, immunization technical working groups, and urban technical committee and in planned regional/global urban immunization workshops, forums, publications, etc.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">By nature, the documentation of best practices and lessons learned is ongoing and will take place throughout the duration of the project. The team is currently in the process of documenting best practices and lessons learned from the situational analysis exercise.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.	Consolidation and documentation of best practices and lessons learned to support adaptation and scalability of urban immunization technical approaches to other urban areas in Zimbabwe and beyond.">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">By nature, the documentation of best practices and lessons learned is ongoing and will take place throughout the duration of the project. The team is currently in the process of documenting the methodology and tool adaptation and development process, and has generated a draft list of topic areas for future documentation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Guidance (to independently conduct situational analysis and develop action plans that address observed equity gaps) developed and shared with the MOHCC and City Health Departments in 9 additional cities (notably Beitbridge, Epworth, Gweru, Hwange Urban, Kadoma City, Masvingo, Mutare, Plumtree, and Goromonzi Peri-urban). 
.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Following the kick off meetings in July 2021, the CoP cities received input virtually on how to conduct a situational analysis. Specifically, JSI shared the situational analysis tools and guidance on how to organise the situational analysis. Mutare city conducted the situational analysis. Other cities cite resource challenges, like financial, competing priorities, and transportation and human resource challenges that prevent them from conducting their own situational analysis.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Urban immunization action plans developed for 2 cities, with technical support from JSI and partners in collaboration with ZEPI.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">As noted previously, Ministry approval delays have also delayed the situational assessments and planning workshops. It is therefore anticipated that these action plans will be developed in the next quarter.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">JSI prepared and finalized the tools for action planning co-creation workshops. JSI will conduct the urban immunization action planning and co-creation workshops together with the microplanning workshops; agenda and workshop materials have been finalized. JSI is awaiting approval from the MoHCC to conduct these workshops. The action plans will be developed during the workshops.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">JSI prepared and finalized the tools for action planning co-creation workshops. JSI will conduct the urban immunization action planning and co-creation workshops together with the microplanning workshops; agenda and workshop materials have been finalized. JSI is awaiting approval from the MoHCC to conduct these workshops. The action plans will be developed during the workshops.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Urban immunization action planning co-creation workshops conducted with the MOHCC/ZEPI, technical partners, and civil society organizations in 2 cities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">JSI prepared and finalized the tools for action planning co-creation workshops. JSI will conduct the urban immunization action planning and co-creation workshops together with the microplanning workshops; agenda and workshop materials have been finalized. JSI is awaiting approval from the MoHCC to conduct these workshops.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">JSI prepared and finalized the tools for action planning co-creation workshops. JSI will conduct the urban immunization action planning and co-creation workshops together with the microplanning workshops; agenda and workshop materials have been finalized. JSI is awaiting approval from the MoHCC to conduct these workshops.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The urban immunization action planning co-creation workshops are to be conducted after data collection and the situational analysis, and therefore are now expected to take place in the next quarter (Q3) due to delays in MOHCC approval to begin the project. Further delays (and alternative/updated approaches to activity implementation) are ancitipated due to recent COVID-19 lockdowns and increased safety concerns in specific regions of Zimbabwe.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Representatives from at least 10 cities receiving technical training on microplanning to reach priority communities and populations with RI in urban settings.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs) in Harare, Bulawayo, Masvingo, and Kwekwe, develop comprehensive micro-plans that reach all children living or seeking vaccination services in city.">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">As previously mentioned, JSI technical support was initially delayed due to unexpected Zimbabwe MOHCC approval processes (due to changes with newly appointed MOHCC leadership, resulting in approval for the planned TA received on 3 May 2021). This has delayed the start and timeline of our activities, including our activity on providing training on creating microplans to city representatives. We expect to be able to complete this activity in Q3, after the situational analysis in each of the four cities is completed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs) in Harare, Bulawayo, Masvingo, and Kwekwe, develop comprehensive micro-plans that reach all children living or seeking vaccination services in city.">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">JSI prepared and finalized the tools for the microplanning workshop. JSI will conduct the microplanning training together with the urban immunization action planning ; agenda and workshop materials have been finalized. JSI is awaiting approval from the MoHCC to conduct these workshops.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Through ongoing (remote) follow-up, monitor extent to which urban-specific activities have been implemented according to microplans.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">JSI will monitor microplan implementation after microplans have been developed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 80% of health facilities in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe) receiving technical support have costed microplans that reach children living or seeking vaccination services in that catchment area, through technical support and skills transfer.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	In collaboration with the MOHCC/ZEPI, City Health Departments, and other partners (i.e., private sector, non-health stakeholders, CBOs), develop 12-month city-specific action plans that address observed equity gaps in each of the 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe).">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Selected health facility staff will be included in the microplanning workshop.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Community of Practice (CoP) through Whatsapp and Boost Platforms on urban immunization for EPI focal points and health workers established across 13 cities to share challenges, solutions, and lessons learned on conducting situational analyses and developing action plans in real time.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.	Consolidation and documentation of best practices and lessons learned to support adaptation and scalability of urban immunization technical approaches to other urban areas in Zimbabwe and beyond.">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">A readiness assessment tool to support rapid insight gathering for the Community of Practice (CoP) design was developed using Survey Monkey. This will help to determine key stakeholders to engage in the CoP platform; gather information from stakeholders on the best modes for communication and provide insight into capacity building needs. After receiving approval from the EPI Manager on June 7, the survey/readiness assessment was sent to Health Promotion Officers, Community Health Nurses, and CBO representatives in the 13 target cities. Survey responses will be analyzed and shared via the National Kickoff meeting in July 2021, where the CoP will be launched. The CoP will include a broad CoP with sub-CoPs that are city-focused. Initial topics for capacity building and sharing include the development/adaptation of the situational analysis methodology and tools, piloting and revision of tools, and how to plan for and organize the situational analsyis. The Community of Practice (CoP) will use the Whatsapp, Zoom and Boost platforms (and will consider other communication channels based on survey feedback) for sharing the best practices and lessons learned.
Link to survey: https://www.surveymonkey.com/r/YCQT35J</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4. Consolidation and documentation of best practices and lessons learned to support adaptation and scalability of urban immunization technical approaches to other urban areas in Zimbabwe and beyond.">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The readiness assessment survey responses were analysed and results were shared during the kick off meetings in July 2021. Results indicated that the communication platforms mainly used were Whatsapp, Zoom, email and Facebook. Results also showed that the following professionals were recommended to participate in the CoP: Nurses (Health Nurses), Health promotion Officers, EPI officers and various partners. Following the readiness assessment, JSI worked with Boost to establish a Private Learning Group for CoP participants, where participants can share challenges, solutions, and lessons learned.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Situational analysis conducted in 4 cities with support from representatives from the MOHCC and City Health Department.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Conduct situational analysis in 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe), in collaboration with the MOHCC/ZEPI National and City Health Departments.">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">As noted previously, there were unforeseen delays in approval for project implementation from newly appointed Ministry leadership, and JSI was delayed in obtaining IRB approval from MRCZ for the situational assessment methodology and tools (received on 17 June 2021). Meanwhile, all provinces--including representatives from the four target cities--have been sensitized to the project during the EPI Review Meeting that took place in 6-8 May 2021 in Masvingo. With the methodology and tools finalized, JSI is waiting for a letter from the Permanent Secretary to carry out the national kick-off meeting (to take place virtually due to COVID-19 lockdown) and training of data collection teams, after which the situational analysis will take place in the 4 cities. Situational analysis will take place in Q3.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Conduct situational analysis in 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe), in collaboration with the MOHCC/ZEPI National and City Health Departments.">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The situational analysis was conducted, starting with the kick off virtual meeting for the 4 priority cities (Harare, Chitungwiza, Bulawayo and Kwekwe) and kick-off for the Community of Practice cities on 14 and 15 July 2021 respectively. The situational analysis report has been completed and submitted to Gavi.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Situational analysis methodology and tools using quantitative and qualitative methods developed for addressing inequities in routine immunization in urban poor communities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Conduct situational analysis in 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe), in collaboration with the MOHCC/ZEPI National and City Health Departments.">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">As noted previously, a change in Ministry leadership resulted in approval delays in project start-up. While navigating the approval process, JSI adapted the global urban immunization toolkit (methodology and tools) and submitted the methodology and tools to JSI IRB for approval, which was approved on May 19, 2021. JSI submitted tools to Zimbabwe IRB on May 26, 2021, and JSI received Zimbabwe IRB approval of the methodology and tools on 17 June 2021. Next steps include: piloting the tools in collaboration with the city data collection teams, making final adjustments to them, then conducting the situational assessments in the four target cities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Conduct situational analysis in 4 cities (Harare, Bulawayo, Chitungwiza, and Kwekwe), in collaboration with the MOHCC/ZEPI National and City Health Departments.">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The training of data collectors for Harare and Chitungwiza was conducted in Harare from 4 - 6 August, 2021. Data collectors were given input on the rationale for the urban situational analysis study, the methodology, and the data collection tools including theuse of ODK on tablets and research ethics. Data collection in Harare and Chitungwiza was done from 11 to 21 August, 2021. The data collectors&apos; training for Kwekwe and Bulawayo was conducted in Kwekwe from 29 August to 01 September. Data collection for Kwekwe and Bulawayo was done 2 - 12 September 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. The implementation of RED/REC routine EPI activities (outreach, supportive supervision, EPI reviews) including campaigns are technically supported to ensure optimal use of resources and coverage of hard to reach populations (# of districts utilizing micro plans ? target all 20 low performing districts; # of recommendations implemented following EPI reviews and supportive supervision) 2. At least 3 demand promotion activities in 2020 are well prepared, implemented in line with the new demand promotion strategy and where possible integrated with other MNCH interventions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support implementation of the RED/REC approach with the aim of increasing coverage of hard to reach populations">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">All districts were trained in RED/REC approach and in microplanning in preparation for the integrated campaign. The skills they have acquired will enable them to implement immunisation activities and also support health centres in operationalization.
Hundred percent of SBCC demand package is now integrated within the RMNCH &amp; N interventions targeted across 63 districts to increase awareness, acceptability and uptake of immunisation services; using the socio-ecological model targeting individual, community and organisational structures through interpersonal communication strategies implemented by a network of more than 16,000 Village Health Workers, health promotion activities at service points, media engagements, mass media campaign to promote vaccination as a prevention strategy and capacity building and orientation of community influencers on benefits of immunisation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 3 field missions are undertaken to monitor implementation of the demand promotion strategy implementation 2. A dashboard of demand promotion indicators is established and shared on a quarterly basis 3. Demand promotion activities for Q1 &amp; Q2 2020 are well planned and in-line with the national demand promotion strategy.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="C4D/SBCC Technical assistance- Health Promotion Officer to be based at the MoHCC central level">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Field missions, documentation of best practices were successfully conducted. Reports of activities and progress on interventions are contained in the reports attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Progress report on RED/REC operationalization in 10 low performing districts 2. At least 3 demand promotion activities in 2019 are well prepared, implemented in line with the new demand promotion strategy and where possible integrated with other MNCH i</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support implementation of the RED/REC approach with the aim of increasing coverage of hard to reach populations">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Operationalization of RED/REC approach will be done Q3 2021 because training was delayed due to COVID-19 lockdown measures and prioritization of the integrated campaign.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. RED/REC new guidelines and tools are finalized and disseminated to the district level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support implementation of the RED/REC approach with the aim of increasing coverage of hard to reach populations">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">RED/REC guidelines completed, all health centres will receive these guidelines by latest July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 10 of the low performing districts receive technical support with implementing RED/REC routine EPI activities, to include micro-planning for more efficient outreach and data management by Q2 2020.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support RED/REC approach implementation in-order to strengthen the country&apos;s immunisation system, improve coverage and reduce equity barriers in immunization among hard to reach populations including urban poor.">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Training in RED/REC was delayed due to COVID-19 lockdown measures. Facility staff will be trained on the RED/REC approach in Q3 to build their capacity in operationalizing the strategy. Technical support will be provided during implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All surviving infants entered in mHealth platform</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA for near Real Time Monitoring and social accountability for EPI">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">mHealth dashboard and mothers&apos; registration workflows have been finalised. Development of business solutions for integration of mHealth, RapidPro into DHIS2 is in progress. User training materials have been finalised, training of users was delayed due to the TCV campaign and is now scheduled for Q3.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of Health Facilities introduce TCV &amp; IPV</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, readiness assessment and roll out of Typhoid conjugate vaccine">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">TCV was eventually rolled out through a catch up campaign conducted period 24 May to 04 June 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TCV PIE Conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out Post Introduction Evaluation of Typhoid vaccine">
      <location ref="ZW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">TCV was supposed have been rolled out in June 2020 and a PIE conducted 6 moths after introduction, but due to Covid-19 pandemic, TCV was only rolled out May/June 2021. A PIE will only be due 6 to 12 months after introduction hence our plan to reprogram this activity to end of this year or early 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out Post Introduction Evaluation of Typhoid vaccine">
      <location ref="ZW"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">TCV was supposed have been rolled out in June 2020 and a PIE conducted 6 moths after introduction, but due to Covid-19 pandemic, TCV was only rolled out May/June 2021. A PIE will only be due 6 to 12 months after introduction hence our plan to reprogram this activity to end of this year or early 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of provincial vaccine stores sharing updated atock management analysis tools (SMT) with national level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;To strengthen vaccine supply chain information systems and data analytics capacity to inform strategic and operational decisions, as well as for enhacing product-visbility capacity
  Carry out support visits to at least 4 provinces and 10 districts to support them on supplies management
  Offer technical support in identifying and trial running of real time LMIS
  Support MOHCC in TCV vaccine introduction specifically monitoring vaccine usage and waste management 
  Provide technical support to conduct a follow up Cold Chain Assessment to the one conducted in 2015
  Technical support for implementation of priority activities in the EVM Comprehensive Improvement Plan
  Provide technical support to Covid-19 vaccination activities especially those related to vaccine supply chain preparations, forecasting, storage and deployment&quot;">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The Covid-19 pandemic disturbed timely implementation of some the planned activities. However, submission of SMTs by provinces improved significantly during period under review with 10/11 provinces of provinces submitting their STMs timely and the national level analyzing them and giving feedback. The LMIS could not not be procured due to Covid19. The plan had been to carry out study tour to a country with a credible LMIS and learn how it was working and then decide on the appropriate tool to procure.. The other activities ere on track and progressing well.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 1 immunisation policy recommendation produced</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="ZIMNITAG to have produced at least 1 immunisation policy recommendation by 30 June 2021">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The ZIMNITAG recommended tetanus doses beyond routine childhood doses to boost immunity against tetanus. This has now been adopted as a policy by MOHCC where all children will now receive extra doses of tetanus vaccine at 5 and 9 years.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="ZIMNITAG to have produced at least 1 immunisation policy recommendation by 30 June 2021">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The ZIMNITAG recommended tetanus doses beyond routine childhood doses to boost immunity against tetanus. This has now been adopted as a policy by MOHCC where all children will now receive extra doses of tetanus vaccine at 5 and 9 years.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Six rounds of supportive supervision conducted in low performing districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to low performing districts">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Integrated EPI support supervision visits were conducted in 12 low performing districts. The support supervison were integrated with COVID-19 vaccination and integrated TCV/IPV/HPV support.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to low performing districts">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Integrated EPI support supervision visits were conducted in 12 low performing districts. The support supervison were integrated with COVID-19 vaccination and integrated TCV/IPV/HPV support.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One training report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Train 10 District Medical Officers and (DMOs) &amp; District Nursing Officers (DNOs) in ten low performing districts on Leadership, Management and Coordination using approach adopted by University of Zimbabwe department of Community Medicine">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The activity could not be conducted due to Covid-19 lockdown. However, plans are now in place to conduct the trainings in 10 districts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Operational Reserach Report availalble</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out district specific operational research to improve service delivery">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Operational research conducted in Chegutu district to assess community knowledge, attitudes and practices towards cholera, and its vaccine as well as to get insights on intend to get a COVID- 19 vaccine. It also assessed current attitudes, practices and relation to routine vaccination especially in the current context of COVID- 19 where circulating rumours may affect uptake of new and routine vaccines. The findings of the survey were used to improve uptake of Oral Cholera Vaccine in the district,</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out district specific operational research to improve service delivery">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The activity was delayed due to COVID-19</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out district specific operational research to improve service delivery">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The activity was delayed due to COVID-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provincial-level dashboards created and incorporated into routine program performance reviews and coupled with supportive supervision</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop mechanisms to improve data utilization and KPI-driven program performance management within focal province and districts">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop mechanisms to improve data utilization and KPI-driven program performance management within focal province and districts">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tailored performance dashboard created to provide data and insight to coordinating committees (e.g. ICC)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop mechanisms to improve data utilization and KPI-driven program performance management within focal province and districts">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop mechanisms to improve data utilization and KPI-driven program performance management within focal province and districts">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI financial plans developed, with strong contingency plans to manage the operational and programmatic risks posed by factors such as exchange rate variation and changing government fiscal policies</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure EPI financial plans for immunization acknowledge risks posed by foreign exchange variation and include prioritized contingency plans">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure EPI financial plans for immunization acknowledge risks posed by foreign exchange variation and include prioritized contingency plans">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure EPI financial plans for immunization acknowledge risks posed by foreign exchange variation and include prioritized contingency plans">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Planning process enhanced to ensure adequate coordination of government, partners, and the ICC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve mechanisms for the coordination and accountability of government and immunization partners">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve mechanisms for the coordination and accountability of government and immunization partners">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National level EPI optimal staffing model developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Map national-level EPI?s workload against staffing">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Map national-level EPI?s workload against staffing">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Map national-level EPI?s workload against staffing">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strong coordinated plans for EPI developed at national level and in focal provinces
Regular progress reviews instituted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Optimize processes and tools for more effective planning and course-correction between national EPI and focal provinces.">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Optimize processes and tools for more effective planning and course-correction between national EPI and focal provinces.">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received. CHAI have engaged with Gavi on these challenges and is currently awaiting further guidance as to how best to proceed with engaging Senior MOHCC leadership on the Gavi LMC work.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Interventions are identified as per prioritized needs, feasibility and sustained impact.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Administer a diagnostic assessment on Management Systems and Capacity and analyse results.">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">The proposed work under this grant is split into 2 phases: Phase 1 involves a diagnostic assessment to further understand the detail of areas pertaining to LMC, the results of which would be used to inform fine-tuning of the activities for Phase 2, and thus the milestones listed here. Initial engagement and authorization for fieldwork has taken longer than expected, putting the project behind the planned timelines for this reporting period. In addition, ZEPI had excluded immunization partners, including CHAI from attending stakeholder meetings and assisting in the vaccines work stream, which have impeded visibility and engagement within the space to date. The exclusions were not directed solely at CHAI but were a result of political changes as well as MOHCC?s intention to carry out an efficient rollout of the COVID-19 vaccine, without having several partner forums to consult with prior to executing decisions and action points. This and other reasons described in the main report including the delays, lockdowns and exclusions have presented a significant challenge to timely implementation of the LMC grant. There have been ongoing efforts by Senior CHAI leadership with Senior MOHCC management to request the necessary approvals to allow this work to go ahead. Final written approval is pending from the MOHCC; however, the team remain ready to re-start this work immediately once received.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2021-2025 cMYP Costing Tool &amp; Narrative available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA for development of new cMYP for the country">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">A roadmap for development of the Immunization Strategic Plan has been developed and agreed to by immunization partners. However, there have delays in moving forward the development of the plan partly due to Covid-19 lockdown that affected most the country plans and partly due to changes of administration of the MOHCC that delayed approval of some activities. However, a greenlight has now been given to take the activity forward.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Terms of Reference &amp; Engagement of Consultant</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA for development of new cMYP for the country">
      <location ref="ZW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">There have been delays in implementation of this activity partly as a result of Covid-19 lockdown that delayed implementation of most planned activities and partly as a result of the coming in of new management of the Ministry that delayed approval for implementation of most planned activities. A green light has now been given for the country to implement the activity.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 5 out of 20 selected low performing districts report MR2 coverage of 80% and MR1-MR2 dropot rate of less than 10% by Q2 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support RED/REC approach implementation in-order to strengthen the country&apos;s immunisation system, improve coverage and reduce equity barriers in immunization among hard to reach populations including urban poor.">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Section will be updated once data is made available by the IP</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support RED/REC approach implementation in-order to strengthen the country&apos;s immunisation system, improve coverage and reduce equity barriers in immunization among hard to reach populations including urban poor.">
      <location ref="ZW"></location>
     </target>
     <actual value="On Track">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Section will be updated once data is made available by the IP</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">With on-site technical support, operationalization of the RED/REC approach in all 20 low performing districts by Q4 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support RED/REC approach implementation in-order to strengthen the country&apos;s immunisation system, improve coverage and reduce equity barriers in immunization among hard to reach populations including urban poor.">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Training of health workers in the RED/REC approach was delayed due to the COVID-19 induced restrictions. Trainers from the 20 low performing districts were trained Q2 2021 and the training will be cascaded to health centre staff Q3 and operationalization will commence thereafter.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Two data and surveillance review and planning meeting reports avaialble</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data management and surveillnce review meetings (one per region)with districts with emphasis on adoption and use of new technologies - GIS and ODK">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Two EPI review meetings were conducted. Participants were mainly drawn from MOHCC national, and provincial , UNICEF, JSI and WHO</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data management and surveillnce review meetings (one per region)with districts with emphasis on adoption and use of new technologies - GIS and ODK">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
      <comment>
       <narrative xml:lang="EN">Two EPI review meetings were conducted. Participants were mainly drawn from MOHCC national, and provincial , UNICEF, JSI and WHO</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support strategic actions for maintaining gains in EPI &amp; reaching the ?fifth child?/ zero dose communities whilst picking up momentum for 95% for MR and 90% DTP3 coverage targets
 
 Support the strengthening immunization service as entry point for provision of complete packages of age specific health services, e.g., HPV for expanding ASRH information, services, menstrual hygiene promotion to support the 2nd decade agenda
 
 Provide technical support to scale up RED/REC as a strategic vehicle for advancing integrated PHC &amp; other comprehensive service delivery platforms.
 
 Support strengthening and monitoring of Institutionalized integrated outreach for EPI including campaigns, ANC, PNC, nutrition services, &amp; targeted curative, chronic and NCD care, especially targeting the most constrained settings">
      <location ref="ZW"></location>
     </target>
     <actual value="Completed">
      <location ref="ZW"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="ZW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="ZW"></location>
     </target>
     <actual>
      <location ref="ZW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="ZW"></location>
     </target>
     <actual>
      <location ref="ZW"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
